Exenatide Cost Breakdown: Brand, Compounded, Insurance and Savings Options

Introduction

Exenatide is one of the cheaper branded GLP-1 drugs in 2026, partly because it is no longer top-of-class for either diabetes or weight loss. Byetta retails around $850 to $1,000 per month and Bydureon BCise around $900 to $1,100 per month at most US pharmacies, before discounts. With AstraZenecas manufacturer savings card, eligible commercially insured patients can pay as little as $25 per fill.

Cash pay through GoodRx and similar discount programs typically lands at $700 to $900 per month. The drug is on most major commercial and Medicare formularies, though step therapy through metformin and a sulfonylurea is common before exenatide is covered. Compounded exenatide is not widely available because the drug is not on the FDA shortage list.

This article walks through actual prices, insurance pathways, manufacturer programs, and how the cost compares with the newer GLP-1 alternatives.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

How Much Does Byetta Cost Without Insurance?

Byetta retail pricing in 2026 runs $850 to $1,000 per pen (one month supply at 10 mcg twice daily). Prices vary by pharmacy. GoodRx coupons typically bring the cash price to $700 to $900. The drug is supplied as 5 mcg or 10 mcg per injection prefilled pens.

Quick Answer: Byetta retails $850-$1,000/month; Bydureon BCise retails $900-$1,100/month

The Byetta pen contains 60 doses, which lasts 30 days at twice-daily dosing. Some pharmacies offer 90-day supplies for a small per-dose discount. There is no generic version of exenatide; it is still under patent in most markets through Amylin/AstraZeneca licensing.

For patients without prescription insurance, Bydureon (weekly) is often a slightly better cash-pay value than Byetta (twice-daily) because the manufacturer prices the weekly product similarly per month despite fewer injections.

How Much Does Bydureon BCise Cost?

Bydureon BCise (weekly 2 mg autoinjector) runs $900 to $1,100 per month at most US pharmacies. Each box contains 4 single-dose autoinjectors. Cash pay through discount programs is typically $750 to $950.

The price is slightly higher than Byetta because of the autoinjector device and the microsphere technology, but the per-month cost difference is small. For patients prioritizing injection convenience (one shot weekly versus 60 shots monthly), Bydureon is the obvious choice.

Long-term cost trends have been roughly flat for exenatide products since 2020, while newer GLP-1 drugs like semaglutide and tirzepatide have seen periodic price increases that put them well above exenatide on cash pay.

What Does Insurance Typically Cover?

Most commercial insurance plans cover Byetta and Bydureon for type 2 diabetes after step therapy through metformin and sometimes a sulfonylurea. Medicare Part D plans cover exenatide on most formularies, usually at tier 2 or tier 3 with copays of $20 to $80 depending on the plan.

Coverage for off-label use (for example, weight loss in patients without type 2 diabetes) is rare. Some employer plans cover GLP-1 drugs for obesity but typically prefer semaglutide (Wegovy®) or tirzepatide (Zepbound®), not exenatide, because exenatide is not approved for obesity.

Medicaid coverage varies by state. Most state Medicaid programs include exenatide on their preferred drug list for type 2 diabetes.

How Does the Manufacturer Savings Card Work?

AstraZenecas exenatide savings card brings copays as low as $25 per month for eligible commercially insured patients. Eligibility requires private insurance (not Medicare, Medicaid, TRICARE, or other federal programs) and a prescription for the FDA-approved indication.

Enrollment is online through the manufacturer website. Patients show the card or savings number to the pharmacy at fill. The card has annual maximum savings limits (typically $1,800 to $2,400 per year, with terms updated periodically).

For uninsured patients who do not qualify for the commercial savings card, AstraZeneca has a patient assistance program that provides free medication based on income criteria. Income limits are roughly 400% of the federal poverty level.

Are There Generic Versions of Exenatide?

No generic exenatide is currently available in the US. The drug is still patent-protected through licensing agreements between Amylin (the original developer), Eli Lilly (original co-marketer), and AstraZeneca (current marketer). Patent expirations for the various exenatide formulations are expected in the late 2020s.

When generics arrive, prices will likely drop 50 to 80% based on typical generic biologics economics, though exenatide is a peptide and may follow a more nuanced biosimilar path rather than a pure small-molecule generic path.

Is Compounded Exenatide Available?

Compounded exenatide is not widely available because the drug is not on the FDA shortage list. Section 503A compounding requires a documented shortage or a specific patient-specific medical need that cant be met by the commercial product. With Byetta and Bydureon both commercially available without supply issues, compounding pharmacies generally do not produce exenatide.

This contrasts with semaglutide and tirzepatide, both of which were on the FDA shortage list (semaglutide from 2022, tirzepatide intermittently) and generated a large compounded supply through 503A pharmacies. TrimRxs personalized treatment plan uses compounded semaglutide and tirzepatide, not exenatide.

If you are looking for a less expensive injectable GLP-1, compounded semaglutide is usually cheaper than retail exenatide.

Key Takeaway: Compounded exenatide is uncommon because exenatide is not on the FDA shortage list

How Does Exenatide Cost Compare with Semaglutide?

Branded Ozempic® (semaglutide for diabetes) runs $1,000 to $1,300 per month retail, slightly higher than exenatide. Branded Wegovy (semaglutide 2.4 mg for obesity) runs $1,300 to $1,500 per month. Compounded semaglutide through telehealth platforms typically runs $200 to $400 per month, well below retail exenatide.

For patients paying cash, compounded semaglutide is usually the lowest-cost GLP-1 option. For patients with insurance covering exenatide but not semaglutide, exenatide can be cheaper at the copay level. The right answer depends on the specific insurance.

A free assessment quiz can help compare your options based on insurance status and treatment goals.

How Does Exenatide Cost Compare with Tirzepatide?

Mounjaro® (tirzepatide for diabetes) and Zepbound (tirzepatide for obesity) retail at $1,000 to $1,400 per month. Both are typically more expensive than exenatide on retail pricing. Compounded tirzepatide ranges $250 to $500 per month depending on the dose and pharmacy.

Tirzepatide produces dramatically more weight loss than exenatide (20.9% vs 4-5%), so the cost per unit of weight loss is much better with tirzepatide even at higher absolute cost. For diabetes alone, exenatide may still be cost-effective if insurance covers it well.

What If You Need to Pay Cash Long-term?

For long-term cash-pay use, the order of cheapest to most expensive for a typical patient looks something like:

1. Compounded semaglutide via telehealth: $200-$400/month
2. Compounded tirzepatide via telehealth: $250-$500/month
3. Generic metformin (not a GLP-1 but cheap): $5-$15/month
4. Exenatide with GoodRx: $700-$900/month
5. Branded Ozempic/Wegovy/Mounjaro/Zepbound: $1,000-$1,500/month

Compounded GLP-1 drugs from a licensed 503A pharmacy with physician oversight produce results similar to the branded versions because the active ingredient is the same. Quality varies by pharmacy.

Are There Hidden Costs to Consider?

Beyond the drug cost, factor in lab monitoring (HbA1c quarterly, kidney function, sometimes lipase if symptoms appear) at $50-$150 per round, telehealth or office visit fees ($75-$300 per visit), and injection supplies (needles for the pen if using Byetta, included with the autoinjector for Bydureon).

Some patients also factor in dietary changes, gym memberships, or registered dietitian visits as part of total cost of care. These usually arent strictly required but can improve outcomes.

How Does Coverage Work for Medicare Patients?

Medicare Part D plans cover exenatide for type 2 diabetes with copays ranging from $20 to $80 monthly depending on the plan and tier placement. Most plans require prior authorization documenting metformin failure or intolerance.

Medicare does not currently cover GLP-1 drugs for weight loss, though this policy may change. Patients with type 2 diabetes who also have obesity can get exenatide covered for the diabetes indication and benefit from the weight loss as well.

Bottom line: TrimRx personalized treatment plans focus on compounded semaglutide and tirzepatide, not exenatide

FAQ

Is Bydureon More Expensive Than Byetta?

Slightly, usually $50 to $100 more per month, but the convenience of weekly versus twice-daily injections makes it the more popular choice.

Can You Use the Manufacturer Savings Card with Medicare?

No. Commercial savings cards are not allowed for Medicare, Medicaid, or other federal program beneficiaries. Patient assistance programs are an alternative pathway.

How Much Does the Autoinjector for Bydureon Cost Separately?

The autoinjector is included with each Bydureon BCise dose. There is no separate purchase. Old-style Bydureon (single-dose vials and prefilled pens) is largely phased out.

What If You Cant Afford Exenatide?

Options include AstraZenecas patient assistance program, switching to compounded semaglutide or tirzepatide via telehealth, asking your prescriber about samples, or starting with generic metformin if you havent already tried it.

Does TrimRx Prescribe Exenatide?

TrimRxs personalized treatment plan focuses on compounded semaglutide and tirzepatide, which produce more weight loss and are typically more affordable than retail exenatide.

Are There Annual Maximums on the Savings Card?

Yes, AstraZenecas savings card has an annual maximum of approximately $1,800 to $2,400 in savings, after which the patient pays the regular insurance copay. The exact amount is set by AstraZeneca and updated periodically.

Will Exenatide Get Cheaper When Generics Arrive?

Likely yes. Patent expirations and biosimilar entry in the late 2020s should bring exenatide prices down substantially, though peptide biosimilars often see smaller price drops than small-molecule generics.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.